U.S. markets open in 2 hours 35 minutes

OrthoPediatrics Corp. (KIDS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
48.59+2.95 (+6.46%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close45.64
Bid0.00 x 900
Ask0.00 x 800
Day's Range46.08 - 49.80
52 Week Range32.21 - 55.98
Avg. Volume208,064
Market Cap950.158M
Beta (5Y Monthly)0.67
PE Ratio (TTM)N/A
EPS (TTM)-1.43
Earnings DateNov 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est55.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • BREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages OrthoPediatrics Corp. Investors with Losses to Inquire About Class Action Investigation - KIDS

    BREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages OrthoPediatrics Corp. Investors with Losses to Inquire About Class Action Investigation - KIDS

    NEW YORK, NY / ACCESSWIRE / January 26, 2021 / Rosen Law Firm:WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of OrthoPediatrics Corp. (NASDAQ: KIDS) resulting from allegations that OrthoPediatrics may have issued materially misleading business information to the investing public.

  • Newsfile

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OrthoPediatrics Corporation - KIDS

    New York, New York--(Newsfile Corp. - January 26, 2021) - Pomerantz LLP is investigating claims on behalf of investors of OrthoPediatrics Corporation ("OrthoPediatrics" or the "Company")(NASDAQ: KIDS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether OrthoPediatrics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the ...

  • GlobeNewswire

    ORTHOPEDIATRICS CORPORATION INVESTOR ALERT: Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In OrthoPediatrics Corporation To Contact Him Directly To Discuss Their Options

    NEW YORK, Jan. 23, 2021 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential violations of the federal securities laws against OrthoPediatrics Corporation (“OrthoPediatrics or the “Company”) (NASDAQ:KIDS). If you suffered losses exceeding $50,000 investing in OrthoPediatrics Corporation securities and would like to discuss your legal rights, click here: www.faruqilaw.com/KIDS or call Faruqi & Faruqi partner James Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). FARUQI & FARUQI, LLP685 Third Avenue, 26th Floor New York, NY 10017877.247.4292212.983.9330jwilson@faruqilaw.com There is no cost or obligation to you. On December 2, 2020, Culper Research (“Culper”) published a that described OrthoPediatrics Corporation as having “engaged in a channel stuffing scheme that has systematically and significantly overstated revenues.” The Culper report alleged that “the Company has abused its ability to book revenues upon shipment by selling and shipping excess product directly to its distributors, many of whom are exclusive to the Company” and described it as "concerning that many of the Company's ‘exclusive distributors’ are simply former OrthoPediatrics employees who have formed their own distributorships, often while still employed at the Company.” On this news, OrthoPediatrics Corporation’s stock price fell $4.12 per share, or 9.13%, to close at $41.02 per share on December 2, 2020. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.